← 홈

전체 프로그램

ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-11 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 4,162개
AntibodyBristol Myers SquibbPhase 2

pembrolizumab (Keytruda, ipilimumab, pembrolizumab, durvalumab, idarubicin, bevacizumab)

Hepatic Cancer; Surgery · Lung Cancer

#LungCancer#Antibody#Phase2#항체#면역항체+4
임상시험 4상태 RECRUITING
CGTBiologicstaleAllife Medical Science and Tech…Phase 1

pd-1 and DC-NK cells (pd-1 and DC-NK cells)

Solid Tumor · PD-1

#PD-1#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 4상태 ACTIVE
ADCBiologicstaleRochePhase 3

polatuzumab vedotin, zanubrutinib, rituximab and lenalidomide (polatuzumab vedotin, zanubrutinib, rituximab and lenalidomide)

Diffuse Large B-Cell Lymphoma · Diffuse Large B-Cell Lymphoma

#DiffuseLargeB-CellLymphoma#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+1
임상시험 4상태 RECRUITING
CGTBiologicstaleBeacon TherapeuticsPhase 2

rAAV2tYF-GRK1-RPGR (rAAV2tYF-GRK1-RPGR)

X-Linked Retinitis Pigmentosa · X-Linked Retinitis Pigmentosa

#X-LinkedRetinitisPigmentosa#CGT#Phase2#세포유전치료#CAR-T+2
임상시험 4상태 RECRUITING
AntibodystaleJanssenPhase 2

daratumumab (Darzalex, 89Zr-daratumumab)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase2#항체#면역항체+2
임상시험 3상태 ACTIVE
CGTAAVBiologicstaleMeiraGTx UK II LtdPhase 2

AAV - CNGB3 (AAV - CNGB3)

Achromatopsia · Achromatopsia

#Achromatopsia#CGT#Phase2#세포유전치료#CAR-T+2
임상시험 3상태 ACTIVE
CGTAAVBiologicstaleLibella Gene TherapeuticsPhase 1

AAV-hTERT (AAV-hTERT)

Alzheimer Disease · Alzheimer Disease

#AlzheimerDisease#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 3상태 ACTIVE
ADCBiologicstaleAbbVie (prior sponsor, Abbott)Phase 1

ABT-700 (ABT-700)

Advanced Solid Tumors · Advanced Solid Tumors

#AdvancedSolidTumors#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 0%임상시험 3상태 ACTIVE
ADCBiologicPfizerPhase 2

ALLR3 (ALLR3)

ACUTE LYMPHOBLASTIC LEUKEMIA · ACUTE LYMPHOBLASTIC LEUKEMIA

#ACUTELYMPHOBLASTICLEUKEMIA#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 3상태 RECRUITING
ADCBiologicQuantumLeap Healthcare Collabor…Phase 2

ARV-471 + Letrozole (ARV-471 + Letrozole)

Breast Neoplasms; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 3상태 RECRUITING
ADCBiologicstaleAstraZenecaPhase 3

AZD5335 (AZD5335)

Epithelial Ovarian Cancer · Ovarian Cancer

#OvarianCancer#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2
임상시험 3상태 RECRUITING
ADCBiologicAstraZenecaPLPhase 2

AZD8205 (AZD8205)

Breast Cancer; Biliary Tract Carcinoma · Breast Cancer

#BreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+4
임상시험 3상태 RECRUITING
AntibodystaleDeutsches Herzzentrum MuenchenApproved

Abciximab (Abciximab)

Acute Myocardial Infarction · Myocardial Infarction

#MyocardialInfarction#Antibody#Approved#항체#면역항체+3
임상시험 3상태 ACTIVE
AntibodystaleAbbVieApproved

ADA (Adalimumab, Adalimumab (ADA))

Rheumatoid Arthritis · Uveitis

#Uveitis#Antibody#Approved#항체#면역항체+3
효능 ORR 3.6%임상시험 3상태 ACTIVE
AntibodyAbbVieApproved

adalimumab (Humira, Adalimumab Dose Intensification)

Crohn Disease (CD) · Crohn Disease (CD)

#CrohnDiseaseCD#Antibody#Approved#항체#면역항체+2
임상시험 3상태 RECRUITING
AntibodyThe First Affiliated Hospital o…Phase 2

Adebellizumab (Adebellizumab)

Resectable Lung Non-Small Cell Carcinoma · Resectable Lung Non-Small Cell Carcinoma

#ResectableLungNon-SmallCellCarci#Antibody#Phase2#항체#면역항체+2
임상시험 3상태 RECRUITING
AntibodystaleGilead SciencesPhase 1

Andecaliximab (Andecaliximab)

Gastric Adenocarcinoma · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase1#항체#면역항체+3
효능 ORR 9.7%임상시험 3상태 DISCONTINUED
CGTBiologicThe First Affiliated Hospital o…Preclinical

Anti-BCMA and CD19 CART cells will be injected intravenously on a one-time basis. (Anti-BCMA and CD19 CART cells will be injected intravenously on a one-time basis.)

Autoimmune Diseases · CD19

#CD19#CGT#Preclinical#세포유전치료#CAR-T+3
임상시험 3상태 RECRUITING
AntibodyUniversity of CalgaryApproved

Anti-IL12/23 or anti-IL23 - Risankizumab (Anti-IL12/23 or anti-IL23 - Risankizumab)

Crohn Disease · Crohn Disease

#CrohnDisease#Antibody#Approved#항체#면역항체+2
임상시험 3상태 RECRUITING
CGTBiologicstaleNational Cancer Institute (NCI)Phase 2

Anti-NY ESO-1 T-cell receptor PBL (Anti-NY ESO-1 T-cell receptor PBL)

Metastatic Melanoma; Metastatic Renal Cell Cancer · Metastatic Melanoma

#MetastaticMelanoma#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 3상태 DISCONTINUED

58 / 209 페이지

← 이전다음 →